Norges Bank
BEAM icon

Norges Bank’s Beam Therapeutics BEAM Stock Holding History

Norges Bank’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,591
Closed -$461K – 1758
2024
Q4 		$461K Hold
18,591
– – ﹤0.01% 1797
2024
Q3 		$455K Sell
18,591
-392,208
-95% -$10.1M ﹤0.01% 1788
2024
Q2 		$9.63M Buy
410,799
+116,108
+39% +$2.85M ﹤0.01% 1406
2024
Q1 		$9.74M Buy
294,691
+281,804
+2,187% +$8.78M ﹤0.01% 1456
2023
Q4 		$351K Sell
12,887
-288,837
-96% -$7.17M ﹤0.01% 1913
2023
Q3 		$7.26M Sell
301,724
-6,910
-2% -$185K ﹤0.01% 1581
2023
Q2 		$9.85M Sell
308,634
-85,629
-22% -$2.78M ﹤0.01% 1537
2023
Q1 		$12.1M Sell
394,263
-103,748
-21% -$4.09M ﹤0.01% 1500
2022
Q4 		$19.5M Buy
498,011
+29,003
+6% +$1.3M ﹤0.01% 1283
2022
Q3 		$22.3M Buy
469,008
+19,119
+4% +$1.09M 0.01% 1155
2022
Q2 		$17.4M Buy
449,889
+162,653
+57% +$6.47M ﹤0.01% 1303
2022
Q1 		$16.5M Buy
287,236
+4,570
+2% +$300K ﹤0.01% 1498
2021
Q4 		$22.5M Sell
282,666
-30,887
-10% -$2.64M ﹤0.01% 1416
2021
Q3 		$27.3M Buy
313,553
+29,492
+10% +$2.96M 0.01% 1288
2021
Q2 		$36.6M Sell
284,061
-25,321
-8% -$2.02M 0.01% 1151
2021
Q1 		$24.8M Buy
+309,382
New +$29.4M 0.01% 1411
2020
Q3 		– Sell
-8,324
Closed -$233K – 2131
2020
Q2 		$233K Sell
8,324
-11,676
-58% -$252K ﹤0.01% 2069
2020
Q1 		$360K Buy
+20,000
New +$435K ﹤0.01% 2020

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank's BEAM Position: Q1 2025 in Review

Norges Bank sold out of Beam Therapeutics (BEAM) in Q1 2025, closing a stake of 18,591 shares — an estimated $461K sold.

Norges Bank first reported a position in BEAM in Q1 2020 and held it in 18 quarters. The position peaked at $36.6M in Q2 2021. 237 funds tracked by Wall St. Rank hold BEAM as of Q1 2025.

  • Norges Bank reported no remaining Beam Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Norges Bank sold 18,591 Beam Therapeutics shares in Q1 2025, an estimated $461K.
  • Norges Bank first reported a position in Beam Therapeutics in Q1 2020 and held it in 18 quarters.
  • Norges Bank's Beam Therapeutics position peaked at $36.6M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.